Filter Results:
(3,603)
Show Results For
- All HBS Web
(6,834)
- People (18)
- News (2,177)
- Research (3,603)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,789)
Show Results For
- All HBS Web
(6,834)
- People (18)
- News (2,177)
- Research (3,603)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,789)
Sort by
- February 2020
- Teaching Note
Theranos: Who Has Blood on Their Hands? (A) and (B)
By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091. View Details
- 29 May 2012
- First Look
First Look: May 29
of strong ties to resistors accruing to the change agent are weaker and may yet turn into liabilities that reduce the likelihood of change adoption. Analyses of longitudinal data from 68 multi-method case studies of organizational change initiatives conducted at the... View Details
Keywords: Sean Silverthorne
- March 2023
- Teaching Note
VideaHealth: Building the AI Factory
By: Karim R. Lakhani
Teaching Note for HBS Case No. 621-021. The case “VideaHealth: Building the AI Factory” examines the creation of dental startup VideaHealth (Videa) and the development of its artificial intelligence (AI)-led business strategy through the eyes of founder and CEO Florian... View Details
- October 2014 (Revised July 2016)
- Supplement
Gilead: Hepatitis C Access Strategy (B)
While the "Gilead: Hepatitis-C Access Strategy (A)" case (HBS No. 515-025) poses questions on what the company should do with respect to hard-hit countries like Egypt and India, the (B) case provides the answer. In both cases, the company chose to pursue a proactive... View Details
Rangan, V. Kasturi. "Gilead: Hepatitis C Access Strategy (B)." Harvard Business School Supplement 515-044, October 2014. (Revised July 2016.)
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (C)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case. View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (C)." Harvard Business School Supplement 195-218, April 1995. (Revised August 1995.)
- May 1993
- Case
Alexander Hospital Gift Shoppe
Herzlinger, Regina E. "Alexander Hospital Gift Shoppe." Harvard Business School Case 193-117, May 1993.
- April 2011
- Supplement
Roche's Acquisition of Genentech (CW)
By: Bo Becker
Spreadsheet for case 210040. View Details
- December 2010
- Teaching Note
Urban Water Partners (TN) (A) and (B)
By: Karthik Ramanna and George Serafeim
Teaching Note for 111016 and 111029. View Details
- August 2010 (Revised January 2013)
- Supplement
Urban Water Partners (B)
By: Karthik Ramanna, George Serafeim and Aldo Sesia
The case explores a new business venture to bring clean water to residents of Dar es Salaam, Tanzania, who otherwise cannot afford it. Management has enough money to get their company through August 2010, but needs more capital thereafter. An HBS alumnus is interested... View Details
Keywords: Human Needs; Accrual Accounting; Financial Statements; Health Industry; Health Industry; Dar es Salaam
Ramanna, Karthik, George Serafeim, and Aldo Sesia. "Urban Water Partners (B)." Harvard Business School Supplement 111-029, August 2010. (Revised January 2013.)
- November 2007
- Class Lecture
The Baby Business (FSS)
By: Debora L. Spar
In vitro fertilization and genetic screening are possible with the advent of biotechnology. International adoptions, surrogacy, and other approaches to family planning are on the rise. But few rules govern these measures, medical costs can be prohibitive, and... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Demand and Consumers; Business and Government Relations; Business and Stakeholder Relations; Genetics; Societal Protocols; Commercialization; Biotechnology Industry; Biotechnology Industry
Spar, Debora L. "The Baby Business (FSS)." Harvard Business School Class Lecture 708-701, November 2007.
- May 1992
- Teaching Note
RU 486 (A) and (B), Teaching Note
Teaching Note for (9-391-050) and (9-391-051). View Details
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
Keywords: Judgments; Ethics; Product Launch; Negotiation; Outcome or Result; Performance; Business and Government Relations; Health Industry; Health Industry; France; Germany; United States
Badaracco, Joseph L., Jr. "RU 486 (A)." Harvard Business School Case 391-050, October 1990. (Revised April 1991.)
- December 1999 (Revised August 2001)
- Case
Millennium Pharmaceuticals, Inc. (A)
By: Stefan H. Thomke and Ashok Nimgade
Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details
Keywords: Cost Management; Financing and Loans; Medical Specialties; Retention; Growth and Development Strategy; Time Management; Product Development; Problems and Challenges; Alliances; Technology; Biotechnology Industry; Biotechnology Industry; Cambridge
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (A)." Harvard Business School Case 600-038, December 1999. (Revised August 2001.)
- 07 Feb 2005
- Research & Ideas
How “Career Imprinting” Shapes Leaders
Abbott's career imprint could be called a "functional career imprint." Baxter generated a disproportionate number of leaders in the biotechnology industry. During the early 1980s, when the biotech industry was just heating up... View Details
Keywords: by Mallory Stark
- 17 Jul 2012
- First Look
First Look: July 17
large set of countries and industries and exploit cross-section and time-series variation in import tariffs to examine the impact of prices on organizational choices. Our empirical results provide strong support for the predictions of the... View Details
Keywords: Sean Silverthorne
- 07 Feb 2007
- Research & Ideas
Dividends from Schumpeter’s Noble Failure
models, individual entrepreneurs, companies, and industries vanish from the scene. In complete contrast to Schumpeter's approach in Business Cycles, no mention of a single business firm occurs over the 403-page length of The General... View Details
Keywords: by Thomas K. McCraw
- October 2006 (Revised May 2007)
- Case
Academia Barilla
By: David E. Bell and Mary L. Shelman
Barilla, the world's largest pasta company, has introduced a new high-quality, high-priced product line that features a range of authentic Italian food products sourced from artisan producers. Management believes the line will appeal to consumers seeking healthier... View Details
Keywords: Supply Chain; Plant-Based Agribusiness; Brands and Branding; Decision Choices and Conditions; Family Ownership; Nutrition; Product Development; Investment; Food and Beverage Industry; Italy
Bell, David E., and Mary L. Shelman. "Academia Barilla." Harvard Business School Case 507-001, October 2006. (Revised May 2007.)
- 19 Jan 2011
- Research & Ideas
Activist Board Members Increase Firm’s Market Value
surprise to industry observers, but the SEC's reaction did. On October 4, the SEC unexpectedly announced that it was indefinitely postponing the implementation of shareholder proxy access, pending the outcome of the lawsuit. A Natural... View Details
Keywords: by Carmen Nobel
- 09 Aug 2006
- Research & Ideas
Career Advancement Without Experience
careers," O'Mahony says. "In addition, they're moving in and out of contract work. There are a number of open research issues here, such as questions of health insurance and retirement. What we did was focus on a very specific... View Details
- 27 Feb 2018
- First Look
First Look at New Research and Ideas, February 27, 2018
December 2017 Journal of Creative Behavior In Pursuit of Everyday Creativity By: Amabile, Teresa M. Abstract—Creativity researchers have long paid careful attention to individual creativity, beginning with studies of well-known geniuses... View Details
Keywords: Sean Silverthorne